Fei Liu1, Jian-Hua Mao2. 1. Department of Nephrology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. 2. Department of Nephrology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China. maojh88@zju.edu.cn.
Abstract
BACKGROUND: Calcineurin inhibitors (CNIs) are commonly given to transplant recipients of kidneys and other solid organs and to patients with immune disorders, such as steroid-resistant nephrotic syndrome, steroid-dependent nephrotic syndrome, and frequent relapse nephrotic syndrome. Although CNIs remain the most effective available immunosuppressant agent, there is clinical concern regarding possible long-term nephrotoxicity. This concern is especially significant in children who have a longer life expectancy and greater growth rate. DATA SOURCES: In this review, we analyzed the literatures to identify original articles that examined use of CNIs in children who received organ transplantation and nephropathy to assess the available evidence of their nephrotoxicity. PubMed, Elsevier, and Tompson ISI Web of Knowledge were searched for identifying relevant papers. RESULTS: Clinical research supports the presence of CNI-related nephrotoxicity. However, some researchers have questioned the prevalence and seriousness of chronic CNIs nephrotoxicity, especially because the pathological lesions typically associated with long-term CNI use are nonspecific. Many researchers have focused on early markers of CNI nephrotoxicity, and the methods that may help prevent and manage nephrotoxicity. CONCLUSIONS: Future research should focus on investigating early markers of CNI nephrotoxicity and strategies for improved immunosuppressant therapy, and developing alternative treatments. CNI-mediated nephrotoxicity should always be taken seriously in clinic.
BACKGROUND: Calcineurin inhibitors (CNIs) are commonly given to transplant recipients of kidneys and other solid organs and to patients with immune disorders, such as steroid-resistant nephrotic syndrome, steroid-dependent nephrotic syndrome, and frequent relapse nephrotic syndrome. Although CNIs remain the most effective available immunosuppressant agent, there is clinical concern regarding possible long-term nephrotoxicity. This concern is especially significant in children who have a longer life expectancy and greater growth rate. DATA SOURCES: In this review, we analyzed the literatures to identify original articles that examined use of CNIs in children who received organ transplantation and nephropathy to assess the available evidence of their nephrotoxicity. PubMed, Elsevier, and Tompson ISI Web of Knowledge were searched for identifying relevant papers. RESULTS: Clinical research supports the presence of CNI-related nephrotoxicity. However, some researchers have questioned the prevalence and seriousness of chronic CNIs nephrotoxicity, especially because the pathological lesions typically associated with long-term CNI use are nonspecific. Many researchers have focused on early markers of CNI nephrotoxicity, and the methods that may help prevent and manage nephrotoxicity. CONCLUSIONS: Future research should focus on investigating early markers of CNI nephrotoxicity and strategies for improved immunosuppressant therapy, and developing alternative treatments. CNI-mediated nephrotoxicity should always be taken seriously in clinic.
Authors: Karlien Cransberg; Marlies Cornelissen; Marc Lilien; Koen Van Hoeck; Jean Claude Davin; Jeroen Nauta Journal: Transplantation Date: 2007-04-27 Impact factor: 4.939
Authors: Marian C Roos-van Groningen; Eduard M Scholten; Patrick M Lelieveld; Ajda T Rowshani; Hans J Baelde; Ingeborg M Bajema; Sandrine Florquin; Frederike J Bemelman; Emile de Heer; Johan W de Fijter; Jan A Bruijn; Michael Eikmans Journal: J Am Soc Nephrol Date: 2006-02-08 Impact factor: 10.121
Authors: Benas Prusinskas; Sinja Ohlsson; Simone Kathemann; Denisa Pilic; Kristina Kampmann; Rainer Büscher; Andreas Paul; Lars Pape; Peter F Hoyer; Elke Lainka Journal: Front Pediatr Date: 2021-06-02 Impact factor: 3.418
Authors: Kristien J Ledeganck; Charlotte Anné; Amandine De Monie; Sarang Meybosch; Gert A Verpooten; Marleen Vinckx; Koen Van Hoeck; Annelies Van Eyck; Benedicte Y De Winter; Dominique Trouet Journal: Nutrients Date: 2018-05-27 Impact factor: 5.717